Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Beiersdorf AG is a leading global skin care company headquartered in Hamburg, Germany, renowned as the inventors of modern skin care since its founding in 1882 by pharmacist Paul C. Beiersdorf. The company specializes in innovative, high-quality products that enhance skin health and well-being, driven by over 140 years of research expertise, including breakthroughs like Thiamidol® for hyperpigmentation and EPICELLINE® for skin rejuvenation. Its iconic portfolio features powerhouse brands such as NIVEA—the world’s largest skin care brand—Eucerin for advanced dermatological solutions, La Prairie luxury skincare, Hansaplast/Elastoplast for wound care, Labello lip care, and others like 8x4 and Aquaphor, alongside the tesa segment offering self-adhesive products for industrial and consumer applications. Employing approximately 22,791 people worldwide, Beiersdorf AG operates in the consumer goods sector, with a strong emphasis on the skin care industry that dominates global cosmetics markets. Guided by its 'Win with Care' strategy and 'Care Beyond Skin' purpose, it serves millions daily through a network of over 160 affiliates, focusing on regional needs via dedicated R&D centers. In the financial markets, Beiersdorf AG represents a key player in the health and beauty sector, underscoring sustained innovation and brand loyalty.
€70.80
+€0.16 (+0.23%)
Price from 5 days ago
13.84% operating margin is respectable but not wide. ROIC at 11.15%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue growth slowed to 0.0%, essentially flat. This is a business that needs a catalyst.
Free cash flow declined 59% versus the prior year, cash generation momentum has weakened.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€9.85B
Net Income (TTM)
€955M
▲ +2.9% YoY
Op. Margin
13.84%
▲ +0.2pp YoY
ROIC
11.15%
▲ +0.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€322M
▼ -59.4% YoY
Op. Cash Flow (TTM)
€622M
▼ -26.7% YoY
Net Debt
-€2.48B
Net Cash Position
Cash & Equiv.
€2.58B
3Y CAGR: +3.8%
3Y CAGR: +8.9%
Continue Research